C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/04 (2006.01) A61K 31/454 (2006.01)
Patent
CA 2261762
Substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6- dioxopiperidin- 3-yl)isoindolines reduce the levels of TNF-alpha in a mammal. A typical embodiment is 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline, having the following formula: (see formula I)
Les 2-(2,6- dioxopipéridine-3-yl)-phtalimides substitués et les 1-oxo-2-(2,6- dioxopipéridine-3-yl)-iso-indolines substituées réduisent les taux de TNF-alpha chez le mammifère. Les formes utilisées sont en particulier 1-oxo-2-(2,6-dioxo-3-méthylpipéridine-3-yl)-4,5,6,7-tétrafluoro-iso-indoline et 1,3-dioxo-2-(2,6-dioxo-3-méthylpipéridine-3-yl)-4-amino-iso-indoline.
Chen Roger Shen-Chu
Muller George W.
Stirling David I.
Celgene Corporation
Smart & Biggar
LandOfFree
Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1669033